About Targeted Therapy Zydelig (Idelalisib)

FDA approved Zydelig (Idelalisib) is a targeted therapy cancer treatment for various types of blood cancers that have relapsed., such as lymphocytic leukemia. Dr. Stephen Lemon, a medical oncologist, describes how this treatment works, as well as what types of side effects it may cause.

Zydelig is a cancer treatment developed by Gilead. Dr. Lemon is medical oncologist who is not affiliated with Gilead.